(Q38137867)

29 August 2017

0 references

Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants (English)

1 reference

29 August 2017

main subject

health risk assessment

1 reference

Mathieu Valcke

1

1 reference

29 August 2017

Kannan Krishnan

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

13 September 2013

1 reference

Journal of Applied Toxicology

29 August 2017

published in

1 reference

29 August 2017

volume

34

1 reference

29 August 2017

issue

3

1 reference

29 August 2017

page(s)

227-240

1 reference

Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration

29 August 2017

cites work

1 reference

A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state*1

21 January 2018

1 reference

A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan.

21 January 2018

1 reference

Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis

21 January 2018

1 reference

Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling

21 January 2018

1 reference

Population toxicokinetics of benzene

21 January 2018

1 reference

Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages

21 January 2018

1 reference

Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms

21 January 2018

1 reference

Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach

21 January 2018

1 reference

Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry

21 January 2018

1 reference

Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry

21 January 2018

1 reference

Issues in using human variability distributions to estimate low-dose risk

21 January 2018

1 reference

The relevance of physical activity for the kinetics of inhaled gaseous substances.

21 January 2018

1 reference

Human variability in hepatic and renal elimination: implications for risk assessment

21 January 2018

1 reference

The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans

21 January 2018

1 reference

Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates

21 January 2018

1 reference

Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

21 January 2018

1 reference

Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment

21 January 2018

1 reference

Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment

21 January 2018

1 reference

Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation).

21 January 2018

1 reference

Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review

21 January 2018

1 reference

Evolution of science-based uncertainty factors in noncancer risk assessment

21 January 2018

1 reference

Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans.

21 January 2018

1 reference

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion.

21 January 2018

1 reference

Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature.

21 January 2018

1 reference

Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: implications for risk assessment

21 January 2018

1 reference

Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents

21 January 2018

1 reference

Review and analysis of inhalation dosimetry methods for application to children's risk assessment

21 January 2018

1 reference

The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes

21 January 2018

1 reference

Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites

21 January 2018

1 reference

Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes.

21 January 2018

1 reference

Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population

21 January 2018

1 reference

Human Hepatic CYP2E1 Expression during Development

21 January 2018

1 reference

A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane.

21 January 2018

1 reference

Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.

21 January 2018

1 reference

Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach

21 January 2018

1 reference

Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth

21 January 2018

1 reference

Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II. 1,1,1-Trichloroethane and trichloroethylene.

21 January 2018

1 reference

Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform

21 January 2018

1 reference

Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene

21 January 2018

1 reference

Interindividual variability in inhibition and induction of cytochrome P450 enzymes

21 January 2018

1 reference

Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver

21 January 2018

1 reference

Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation

21 January 2018

1 reference

Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment.

21 January 2018

1 reference

Toxicodynamics of low level toxicant interactions of biological significance: inhibition of tissue repair

21 January 2018

1 reference

Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scaling

21 January 2018

1 reference

Bisphenol A levels in blood depend on age and exposure.

21 January 2018

1 reference

Chemical-specific adjustment factors for intraspecies variability of acetone toxicokinetics using a probabilistic approach.

21 January 2018

1 reference

Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity

21 January 2018

1 reference

Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.

21 January 2018

1 reference

Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.

21 January 2018

1 reference

Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds

21 January 2018

1 reference

Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors

21 January 2018

1 reference

Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children

21 January 2018

1 reference

Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling

21 January 2018

1 reference

Safety factors and establishment of acceptable daily intakes

21 January 2018

1 reference

Data-derived safety factors for the evaluation of food additives and environmental contaminants

21 January 2018

1 reference

Delayed ontogenesis of CYP1A2 in the human liver

21 January 2018

1 reference

Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling

21 January 2018

1 reference

Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling

21 January 2018

1 reference

A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans

21 January 2018

1 reference

An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants

21 January 2018

1 reference

An assessment of the impact of physico-chemical and biochemical characteristics on the human kinetic adjustment factor for systemic toxicants.

21 January 2018

1 reference

Assessing the impact of child/adult differences in hepatic first-pass effect on the human kinetic adjustment factor for ingested toxicants

21 January 2018

1 reference

Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach

21 January 2018

1 reference

Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences

21 January 2018

1 reference

Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach

21 January 2018

1 reference

The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene

21 January 2018

1 reference

Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JAT.2919

1 reference

29 August 2017

1 reference